Skip to main content
ARS Home » Research » Publications at this Location » Publication #255435

Title: Genome-Wide Identification of Allele-specific Expression (ASE) in Response to Marek's Disease Virus Infection Using Next Generation Sequencing

Author
item MACEACHERN, SEAN - Cobb-Vantress, Inc
item MUIR, WILLIAM - Purdue University
item CROSBY, SETH - Washington University
item Cheng, Hans

Submitted to: Meeting Proceedings
Publication Type: Proceedings
Publication Acceptance Date: 6/15/2010
Publication Date: 6/15/2010
Citation: MacEachern, S., Muir, W.M., Crosby, S., Cheng, H.H. 2011. Genome-wide identification of allele-specific expression (ASE) in response to Marek's disease virus infection using next generation sequencing. Biomed Central (BMC) Proceedings. 5(Suppl 4):S14. Available on-line at: http://www.biomedcentral.com/1753-6561/5/S4/S14.

Interpretive Summary:

Technical Abstract: Background: Marek’s disease (MD), a T cell lymphoma induced by the highly oncogenic a-herpesvirus Marek’s disease virus (MDV), is the main chronic infectious disease concern threatening the poultry industry. Enhancing genetic resistance to MD in commercial poultry is an attractive method to augment MD vaccines, and is currently the control method of choice. In order to optimally implement this control strategy through marker-assisted selection (MAS) and to gain biological information, it is necessary to identify specific genes that influence MD incidence. Methods: A genome-wide screen for allele-specific expression (ASE) in response to MDV infection was conducted. The highly inbred ADOL chicken lines 6 (MD resistant) and 7 (MD susceptible) were intermated in reciprocal crosses and half of the progeny challenged with MDV. Splenic RNA pools at a single time after infection for each treatment group point were generated, sequenced using a next generation sequencer, then analyzed for allele-specific expression (ASE). To validate and extend the results, Illumina GoldenGate assays for selected cSNPs were developed and used on all RNA samples from all 6 time points following MDV challenge. Results: RNA sequencing resulted in 11-13+ million mappable reads per treatment group, 1.7+ Gb total sequence, and 22,655 high-confidence cSNPs. Analysis of these cSNPs revealed that 5360 cSNPs in 3773 genes exhibited statistically significant allelic imbalance. Of the 1536 GoldenGate assays, 1465 were successfully scored with all but 19 exhibiting evidence for allelic imbalance. Conclusions: ASE is an efficient method to identify potentially all or most of the genes for this complex trait. The identified cSNPs can be further evaluated in resource populations to determine their allelic direction and size of effect on genetic resistance to MD as well as be directly implemented in genomic selection programs. The described method, although demonstrated in inbred chicken lines, is applicable to all traits in any diploid species, and should prove to be a facile method to identify the majority of genes controlling any complex trait.